Health
Australia to trial ‘backup’ COVID-19 vaccines that can be modified to fight virus mutations – ABC News
Researchers behind a clinical trial of two COVID-19 vaccines in Australia say they will be able to modify the vaccinations if mutations of the virus occur.
Researchers behind a clinical trial of two COVID-19 vaccines in Australia say they will be able to modify the vaccinations if mutations of the virus occur.
Key points:
- Researchers say the mRNA-based vaccine and recombinant protein vaccine being trialled are more targeted
- The Doherty Institute’s Terry Nolan says it is vital Australia has its own vaccine to prevent supply chain issues
- The trials have been expedited to mid-2021 with Federal Government funding
Close to $1.6 million of Federal Government…
Continue Reading
-
Noosa News24 hours agoBrisbane’s covert cameras catching more than just litterbugs
-
Business9 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Business13 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Noosa News13 hours agoShow your Anzac Spirit on the ‘Troop Train’